EVGN CIK: 1574565

Evogene Ltd.

  • Israel
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
0.16
FY22:
0.77
FY23:
1.49
FY24:
3.20
FY25:
−0.24
(positive)
Change from FY21 to FY25
millions USD
FY21:
−31.0
FY22:
−26.9
FY23:
−22.2
FY24:
−18.8
FY25:
−14.0
(positive)
Change from FY21 to FY25
millions USD
FY21:
−30.4
FY22:
−29.8
FY23:
−21.9
FY24:
−14.8
FY25:
−13.5
(positive)
Change from FY21 to FY25
millions USD
FY21:
−30.4
FY22:
−29.8
FY23:
−26.0
FY24:
−18.1
FY25:
−7.83

All amounts in millions USD Data source:SEC EDGAR